Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Profit After Tax: 2020-2024

Historic Profit After Tax for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to -$140.0 million.

  • Arcutis Biotherapeutics' Profit After Tax rose 117.84% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 77.33%. This contributed to the annual value of -$140.0 million for FY2024, which is 46.58% up from last year.
  • As of FY2024, Arcutis Biotherapeutics' Profit After Tax stood at -$140.0 million, which was up 46.58% from -$262.1 million recorded in FY2023.
  • Arcutis Biotherapeutics' Profit After Tax's 5-year high stood at -$135.7 million during FY2020, with a 5-year trough of -$311.5 million in FY2022.
  • Its 3-year average for Profit After Tax is -$237.9 million, with a median of -$262.1 million in 2023.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 52.09% in 2021, then surged by 46.58% in 2024.
  • Over the past 5 years, Arcutis Biotherapeutics' Profit After Tax (Yearly) stood at -$135.7 million in 2020, then crashed by 52.09% to -$206.4 million in 2021, then tumbled by 50.93% to -$311.5 million in 2022, then rose by 15.83% to -$262.1 million in 2023, then spiked by 46.58% to -$140.0 million in 2024.